Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma.
暂无分享，去创建一个
Junnian Zheng | K. Qi | Kailin Xu | Jiang Cao | Hai Cheng | Zhi-ling Yan | Zhenyu Li | Ming Shi | W. Sang | Depeng Li | F. Zhu | Huan-xin Zhang | Ying Wang | Hai-ying Sun | Hu-jun Li | Xue Wang | Guangjun Jing | Wei Chen | R. Bhansali | Yang Liu | M. Shi